Koyfin Home > Directory > Health Care > Acceleron Pharma > Total Debt / Capital

Acceleron Pharma Total Debt / Capital Chart (XLRN)

Acceleron Pharma annual/quarterly Total Debt / Capital from 2012 to 2020.
  • Acceleron Pharma Total Debt / Capital for the quarter ending June 06, 2020 was $5m a -7.35% decrease of 0m year over year
  • Acceleron Pharma Total Debt / Capital for the last 12 months ending June 06, 2020 was $5m a -7.35% decrease of 0m year over year
  • Acceleron Pharma Annual Total Debt / Capital for 2019 was $6m a -307.38% decrease of -17m from 2018
  • Acceleron Pharma Annual Total Debt / Capital for 2013 was $23m a 12,052.00% increase of 2,722m from 2012
  • Acceleron Pharma Annual Total Debt / Capital for 2012 was $-2,700m a 101.40% decrease of -2,737m from 2011
Other Ratios Metrics:
  • Acceleron Pharma Other Liabilities for the quarter ending December 12, 2018 was $4m a 14.46% increase of 1m year over year
  • Acceleron Pharma Total Debt / Equity for the quarter ending December 12, 2013 was $29m
View Chart On Koyfin

Quarterly XLRN Total Debt / Capital Data

06/2020$5m
03/2020$6m
12/2019$6m
09/2019$6m
06/2019$6m
03/2019$6m
12/2013$23m
09/2013$20m
06/2013$135m
03/2013$1,435m

Annual XLRN Total Debt / Capital Data

2019$6m
2013$23m
2012$-2,700m
2011$38m